Gilde Healthcare’s most common sectors for investment are life science (50%) and medical products (23%). The Firm’s most common investment types include venture (78%) and growth capital (14%). In total, Gilde Healthcare has invested in 3 US states and 9 different countries.
In the last 3 years, Gilde Healthcare has exited 6 companies. The Firm’s most common exit type is trade sale (53%). Gilde Healthcare’s largest (disclosed) exit occurred in 2014 when it sold Santaris Pharma A/S for $250M.
Join Mergr to view Gilde Healthcare’s full profile and discover more middle-market private equity firms just like it.
Gilde Healthcare is a specialist private equity and venture investor focused on the healthcare sector. The Firm's buyout group targets majority investments throughout Europe (preference for Germany, the Netherlands, Belgium, Austria or Switzerland) and has a focus on healthcare providers, suppliers and service providers active in the healthcare market. The Firm's venture group looks to invest up to €30 million in early stage medtech, diagnostics, digital health and therapeutics companies throughout North America and Europe. Gilde Healthcare was established in 2001 and is headquartered in Utrecht, the Netherlands.
Join Mergr to view the latest updates and news from Gilde Healthcare.
We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.
Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.
Try us for 1 week free today!
No obligation. Cancel anytime.